Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: IMARC | PRODUCT CODE: 1347577

Cover Image

PUBLISHER: IMARC | PRODUCT CODE: 1347577

Genetic Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028

PUBLISHED:
PAGES: 144 Pages
DELIVERY TIME: 2-3 business days
SELECT AN OPTION
PDF & Excel (Single User License)
USD 2499
PDF & Excel (5 User License)
USD 3499
PDF & Excel (Corporate License)
USD 4499

Add to Cart

Market Overview:

The global genetic testing market size reached US$ 15.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 29.0 Billion by 2028, exhibiting a growth rate (CAGR) of 10.37% during 2023-2028.

Genetic testing, or deoxyribonucleic acid (DNA) testing, refers to a medical technique that identifies changes in the chromosome structure or DNA sequence. It includes the collection and analysis of individual blood samples for examining the genetic condition and the chances of developing or passing various inherited disorders in laboratory settings. Genetic testing assists in providing accurate results regarding gene mutation, eliminating the need for unnecessary checkups, and making informed decisions to manage health. At present, genetic testing is commercially available in varying types, such as carrier, diagnostic, predictive, presymptomatic and prenatal testing.

Genetic Testing Market Trends:

The increasing prevalence of genetic and chronic disorders across the growth represents the key factor driving the genetic testing market growth. This is further supported by the implementation of numerous favorable initiatives undertaken by the government bodies and non-governmental organizations (NGOs) for sensitizing masses regarding genetic testing. In line with this, the extensive utilization of genetic testing in pharmacogenomics, or drug-gene testing for examining the response of the body against certain medicines after its interaction with inherited genes, is contributing as another growth-inducing factor. Additionally, the sudden outbreak of coronavirus disease (COVID-19) pandemic has led to the widespread adoption of virtual testing and the home testing kits for sample collection purposes, which, in turn, is contributing to the market growth. The tremendous technological advancements in genetic testing techniques along with the introduction of DTC-GT (Direct-to-consumer genetic testing) kits are further propelling the market growth. Other factors, such as rising investments in the research and development (R&D) activities in the field of medical science, along with the strategic collaboration amongst top players for launching advanced personalized genetic testing kits, are creating a positive outlook for the market.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global genetic testing market report, along with forecasts at the global, regional and country level from 2023-2028. Our report has categorized the market based on type, technology and application.

Breakup by Type:

Predictive and Presymptomatic Testing

Carrier Testing

Prenatal and Newborn Testing

Diagnostic Testing

Pharmacogenomic Testing

Others

Breakup by Technology:

Cytogenetic Testing and Chromosome Analysis

Biochemical Testing

Molecular Testing

DNA Sequencing

Others

Breakup by Application:

Cancer Diagnosis

Genetic Disease Diagnosis

Cardiovascular Disease Diagnosis

Others

Breakup by Region:

North America

United States

Canada

Asia-Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

Competitive Landscape:

The competitive landscape of the industry has also been examined along with the profiles of the key players being 23andme Inc., Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.), Bio-RAD Laboratories Inc., Cepheid (Danaher Corporation), Eurofins Scientific, Illumina Inc., Invitae Corporation, Luminex Corporation (DiaSorin), Myriad Genetics Inc., QIAGEN, Quest Diagnostics and Thermo Fisher Scientific.

Key Questions Answered in This Report:

  • How has the global genetic testing market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the global genetic testing market?
  • What are the key regional markets?
  • What is the breakup of the market based on the type?
  • What is the breakup of the market based on the technology?
  • What is the breakup of the market based on the application?
  • What are the various stages in the value chain of the industry?
  • What are the key driving factors and challenges in the industry?
  • What is the structure of the global genetic testing market and who are the key players?
  • What is the degree of competition in the industry?
Product Code: SR112023A5788

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genetic Testing Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 Predictive and Presymptomatic Testing
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Carrier Testing
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast
  • 6.3 Prenatal and Newborn Testing
    • 6.3.1 Market Trends
    • 6.3.2 Market Forecast
  • 6.4 Diagnostic Testing
    • 6.4.1 Market Trends
    • 6.4.2 Market Forecast
  • 6.5 Pharmacogenomic Testing
    • 6.5.1 Market Trends
    • 6.5.2 Market Forecast
  • 6.6 Others
    • 6.6.1 Market Trends
    • 6.6.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Cytogenetic Testing and Chromosome Analysis
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Biochemical Testing
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Molecular Testing
    • 7.3.1 Market Trends
    • 7.3.2 Key Segments
      • 7.3.2.1 DNA Sequencing
      • 7.3.2.1 Others
    • 7.3.3 Market Forecast

8 Market Breakup by Application

  • 8.1 Cancer Diagnosis
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Genetic Disease Diagnosis
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Cardiovascular Disease Diagnosis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Others
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast

9 Market Breakup by Region

  • 9.1 North America
    • 9.1.1 United States
      • 9.1.1.1 Market Trends
      • 9.1.1.2 Market Forecast
    • 9.1.2 Canada
      • 9.1.2.1 Market Trends
      • 9.1.2.2 Market Forecast
  • 9.2 Asia-Pacific
    • 9.2.1 China
      • 9.2.1.1 Market Trends
      • 9.2.1.2 Market Forecast
    • 9.2.2 Japan
      • 9.2.2.1 Market Trends
      • 9.2.2.2 Market Forecast
    • 9.2.3 India
      • 9.2.3.1 Market Trends
      • 9.2.3.2 Market Forecast
    • 9.2.4 South Korea
      • 9.2.4.1 Market Trends
      • 9.2.4.2 Market Forecast
    • 9.2.5 Australia
      • 9.2.5.1 Market Trends
      • 9.2.5.2 Market Forecast
    • 9.2.6 Indonesia
      • 9.2.6.1 Market Trends
      • 9.2.6.2 Market Forecast
    • 9.2.7 Others
      • 9.2.7.1 Market Trends
      • 9.2.7.2 Market Forecast
  • 9.3 Europe
    • 9.3.1 Germany
      • 9.3.1.1 Market Trends
      • 9.3.1.2 Market Forecast
    • 9.3.2 France
      • 9.3.2.1 Market Trends
      • 9.3.2.2 Market Forecast
    • 9.3.3 United Kingdom
      • 9.3.3.1 Market Trends
      • 9.3.3.2 Market Forecast
    • 9.3.4 Italy
      • 9.3.4.1 Market Trends
      • 9.3.4.2 Market Forecast
    • 9.3.5 Spain
      • 9.3.5.1 Market Trends
      • 9.3.5.2 Market Forecast
    • 9.3.6 Russia
      • 9.3.6.1 Market Trends
      • 9.3.6.2 Market Forecast
    • 9.3.7 Others
      • 9.3.7.1 Market Trends
      • 9.3.7.2 Market Forecast
  • 9.4 Latin America
    • 9.4.1 Brazil
      • 9.4.1.1 Market Trends
      • 9.4.1.2 Market Forecast
    • 9.4.2 Mexico
      • 9.4.2.1 Market Trends
      • 9.4.2.2 Market Forecast
    • 9.4.3 Others
      • 9.4.3.1 Market Trends
      • 9.4.3.2 Market Forecast
  • 9.5 Middle East and Africa
    • 9.5.1 Market Trends
    • 9.5.2 Market Breakup by Country
    • 9.5.3 Market Forecast

10 SWOT Analysis

  • 10.1 Overview
  • 10.2 Strengths
  • 10.3 Weaknesses
  • 10.4 Opportunities
  • 10.5 Threats

11 Value Chain Analysis

12 Porters Five Forces Analysis

  • 12.1 Overview
  • 12.2 Bargaining Power of Buyers
  • 12.3 Bargaining Power of Suppliers
  • 12.4 Degree of Competition
  • 12.5 Threat of New Entrants
  • 12.6 Threat of Substitutes

13 Price Analysis

14 Competitive Landscape

  • 14.1 Market Structure
  • 14.2 Key Players
  • 14.3 Profiles of Key Players
    • 14.3.1 23andme Inc.
      • 14.3.1.1 Company Overview
      • 14.3.1.2 Product Portfolio
    • 14.3.2 Ambry Genetics Corporation (Konica Minolta Healthcare Americas Inc.)
      • 14.3.2.1 Company Overview
      • 14.3.2.2 Product Portfolio
    • 14.3.3 Bio-RAD Laboratories Inc.
      • 14.3.3.1 Company Overview
      • 14.3.3.2 Product Portfolio
      • 14.3.3.3 Financials
      • 14.3.3.4 SWOT Analysis
    • 14.3.4 Cepheid (Danaher Corporation)
      • 14.3.4.1 Company Overview
      • 14.3.4.2 Product Portfolio
      • 14.3.4.3 SWOT Analysis
    • 14.3.5 Eurofins Scientific
      • 14.3.5.1 Company Overview
      • 14.3.5.2 Product Portfolio
      • 14.3.5.3 Financials
      • 14.3.5.4 SWOT Analysis
    • 14.3.6 Illumina Inc.
      • 14.3.6.1 Company Overview
      • 14.3.6.2 Product Portfolio
      • 14.3.6.3 Financials
      • 14.3.6.4 SWOT Analysis
    • 14.3.7 Invitae Corporation
      • 14.3.7.1 Company Overview
      • 14.3.7.2 Product Portfolio
      • 14.3.7.3 Financials
    • 14.3.8 Luminex Corporation (DiaSorin)
      • 14.3.8.1 Company Overview
      • 14.3.8.2 Product Portfolio
      • 14.3.8.3 SWOT Analysis
    • 14.3.9 Myriad Genetics Inc.
      • 14.3.9.1 Company Overview
      • 14.3.9.2 Product Portfolio
      • 14.3.9.3 Financials
      • 14.3.9.4 SWOT Analysis
    • 14.3.10 QIAGEN
      • 14.3.10.1 Company Overview
      • 14.3.10.2 Product Portfolio
      • 14.3.10.3 Financials
      • 14.3.10.4 SWOT Analysis
    • 14.3.11 Quest Diagnostics
      • 14.3.11.1 Company Overview
      • 14.3.11.2 Product Portfolio
      • 14.3.11.3 Financials
      • 14.3.11.4 SWOT Analysis
    • 14.3.12 Thermo Fisher Scientific
      • 14.3.12.1 Company Overview
      • 14.3.12.2 Product Portfolio
      • 14.3.12.3 Financials
      • 14.3.12.4 SWOT Analysis
Product Code: SR112023A5788

List of Figures

  • Figure 1: Global: Genetic Testing Market: Major Drivers and Challenges
  • Figure 2: Global: Genetic Testing Market: Sales Value (in Billion US$), 2017-2022
  • Figure 3: Global: Genetic Testing Market Forecast: Sales Value (in Billion US$), 2023-2028
  • Figure 4: Global: Genetic Testing Market: Breakup by Type (in %), 2022
  • Figure 5: Global: Genetic Testing Market: Breakup by Technology (in %), 2022
  • Figure 6: Global: Genetic Testing Market: Breakup by Application (in %), 2022
  • Figure 7: Global: Genetic Testing Market: Breakup by Region (in %), 2022
  • Figure 8: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 9: Global: Genetic Testing (Predictive and Presymptomatic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 10: Global: Genetic Testing (Carrier Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 11: Global: Genetic Testing (Carrier Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 12: Global: Genetic Testing (Prenatal and Newborn Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 13: Global: Genetic Testing (Prenatal and Newborn Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 14: Global: Genetic Testing (Diagnostic Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 15: Global: Genetic Testing (Diagnostic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 16: Global: Genetic Testing (Pharmacogenomic Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 17: Global: Genetic Testing (Pharmacogenomic Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 18: Global: Genetic Testing (Other Types) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 19: Global: Genetic Testing (Other Types) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 20: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 21: Global: Genetic Testing (Cytogenetic Testing and Chromosome Analysis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 22: Global: Genetic Testing (Biochemical Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 23: Global: Genetic Testing (Biochemical Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 24: Global: Genetic Testing (Molecular Testing) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 25: Global: Genetic Testing (Molecular Testing) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 26: Global: Genetic Testing (Cancer Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 27: Global: Genetic Testing (Cancer Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 28: Global: Genetic Testing (Genetic Disease Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 29: Global: Genetic Testing (Genetic Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 30: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 31: Global: Genetic Testing (Cardiovascular Disease Diagnosis) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 32: Global: Genetic Testing (Other Applications) Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 33: Global: Genetic Testing (Other Applications) Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 34: North America: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 35: North America: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 36: United States: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 37: United States: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 38: Canada: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 39: Canada: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 40: Asia-Pacific: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 41: Asia-Pacific: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 42: China: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 43: China: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 44: Japan: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 45: Japan: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 46: India: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 47: India: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 48: South Korea: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 49: South Korea: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 50: Australia: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 51: Australia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 52: Indonesia: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 53: Indonesia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 54: Others: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 55: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 56: Europe: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 57: Europe: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 58: Germany: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 59: Germany: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 60: France: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 61: France: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 62: United Kingdom: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 63: United Kingdom: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 64: Italy: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 65: Italy: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 66: Spain: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 67: Spain: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 68: Russia: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 69: Russia: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 70: Others: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 71: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 72: Latin America: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 73: Latin America: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 74: Brazil: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 75: Brazil: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 76: Mexico: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 77: Mexico: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 78: Others: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 79: Others: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 80: Middle East and Africa: Genetic Testing Market: Sales Value (in Million US$), 2017 & 2022
  • Figure 81: Middle East and Africa: Genetic Testing Market: Breakup by Country (in %), 2022
  • Figure 82: Middle East and Africa: Genetic Testing Market Forecast: Sales Value (in Million US$), 2023-2028
  • Figure 83: Global: Genetic Testing Industry: SWOT Analysis
  • Figure 84: Global: Genetic Testing Industry: Value Chain Analysis
  • Figure 85: Global: Genetic Testing Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genetic Testing Market: Key Industry Highlights, 2022 and 2028
  • Table 2: Global: Genetic Testing Market Forecast: Breakup by Type (in Million US$), 2023-2028
  • Table 3: Global: Genetic Testing Market Forecast: Breakup by Technology (in Million US$), 2023-2028
  • Table 4: Global: Genetic Testing Market Forecast: Breakup by Application (in Million US$), 2023-2028
  • Table 5: Global: Genetic Testing Market Forecast: Breakup by Region (in Million US$), 2023-2028
  • Table 6: Global: Genetic Testing Market: Competitive Structure
  • Table 7: Global: Genetic Testing Market: Key Players
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!